Nautilus Biotechnology, Inc.
Hedge Funds Holdings
Last updated:
Nautilus Biotechnology, Inc.‘s stocks are currently a part of 46 hedge funds’ portfolios, which represents 18.54% of the total amount of its stocks outstanding. This makes up a total of 23.09M shares of Nautilus Biotechnology, Inc.. Compared to the previous quarter, the number fell by -49.86% or -22.96M shares fewer. As for the holding position changes, 34.78% (16) of current hedge fund investors increased the number of shares held, 26.09% (12) of current holders sold a part of the shares held, and 13.04% (6) closed the holdings completely. 3 hedge funds are new holders of Nautilus Biotechnology, Inc. stock in Q1 2023, it is 6.52% of total holders.
Hedge funds holding Nautilus Biotechnology (Q2 2021 – Q1 2023)
| Q2 2021 | 56 |
|---|---|
| Q3 2021 | 69 |
| Q4 2021 | 79 |
| Q1 2022 | 81 |
| Q2 2022 | 81 |
| Q3 2022 | 82 |
| Q4 2022 | 78 |
| Q1 2023 | 46 |
Hedge funds changes in Nautilus Biotechnology positions (Q2 2021 – Q1 2023)
| Q2 2021 | 56 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2021 | 21 | 19 | 9 | 8 | 12 |
| Q4 2021 | 22 | 23 | 13 | 12 | 9 |
| Q1 2022 | 17 | 21 | 16 | 15 | 12 |
| Q2 2022 | 22 | 18 | 18 | 22 | 1 |
| Q3 2022 | 10 | 18 | 23 | 9 | 22 |
| Q4 2022 | 10 | 20 | 18 | 12 | 18 |
| Q1 2023 | 3 | 16 | 12 | 6 | 9 |
Hedge funds changes in Nautilus Biotechnology stock options (Q2 2021 – Q1 2023)
| Q2 2021 | 294,000 | 250,000 |
|---|---|---|
| Q3 2021 | 1,002,000 | 310,000 |
| Q4 2021 | 2,037,000 | 324,000 |
| Q1 2022 | 586,000 | 92,000 |
| Q2 2022 | 37,000 | 2,000 |
| Q3 2022 | 9,000 | 0 |
| Q4 2022 | 2,700 | 0 |
| Q1 2023 | 0 | 681,257,000 |